Bank of America’s Codiak BioSciences, Inc. Common Stock CDAK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-53,055
| Closed | -$9.23K | – | 7142 |
|
|
2023
Q1 | $9.23K | Buy |
53,055
+4,483
| +9% | +$780 | ﹤0.01% | 6111 |
|
|
2022
Q4 | $19.3K | Buy |
48,572
+34,016
| +234% | +$13.5K | ﹤0.01% | 5950 |
|
|
2022
Q3 | $11K | Buy |
14,556
+14,408
| +9,735% | +$10.9K | ﹤0.01% | 6350 |
|
|
2022
Q2 | $0 | Sell |
148
-49,495
| -100% | – | ﹤0.01% | 7634 |
|
|
2022
Q1 | $311K | Buy |
49,643
+41,009
| +475% | +$257K | ﹤0.01% | 5425 |
|
|
2021
Q4 | $96K | Buy |
8,634
+1,517
| +21% | +$16.9K | ﹤0.01% | 6071 |
|
|
2021
Q3 | $117K | Buy |
7,117
+2,855
| +67% | +$46.9K | ﹤0.01% | 5775 |
|
|
2021
Q2 | $79K | Sell |
4,262
-4,117
| -49% | -$76.3K | ﹤0.01% | 5832 |
|
|
2021
Q1 | $126K | Sell |
8,379
-4,303
| -34% | -$64.7K | ﹤0.01% | 5623 |
|
|
2020
Q4 | $409K | Buy |
+12,682
| New | +$409K | ﹤0.01% | 4453 |
|